Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Price to Cash Earnings (PCE)

    Back to All Ratios
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   PCE(x) 28.35-21.6327.368.439.27

What is the latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS ?

The latest Price to Cash Earnings (PCE) ratio of GLENMARK PHARMACEUTICALS is 28.35 based on Mar2025 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202528.35
Mar2024-21.63
Mar202327.36
Mar20228.43
Mar20219.27

How is Price to Cash Earnings (PCE) of GLENMARK PHARMACEUTICALS Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2025 28.35
Positive
Mar2024 -21.63
Negative
Mar2023 27.36
224.56
Mar2022 8.43
-9.06
Mar2021 9.27 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Price to Cash Earnings (PCE) ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹63,097.1 Cr -2.9% 4.7% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹463,815.0 Cr 0.5% 6.2% 17.3% Stock Analytics
DIVIS LABORATORIES ₹192,678.0 Cr 4.7% 9% 7% Stock Analytics
TORRENT PHARMACEUTICALS ₹161,323.0 Cr -3.7% 7.2% 49.8% Stock Analytics
CIPLA ₹114,585.0 Cr -0.6% 5% -3.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,067.0 Cr -1.9% -4.6% -2.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-2.9%

4.7%

20.1%

SENSEX

0.8%

1.8%

-6.5%


You may also like the below Video Courses